Nova Patents
IS6207A

Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use

Abstract

Indazole compounds that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction and thereby modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.

Term

Term ended

Projected expiry passed 19 December 2021, 4.8 years ago.

  1. Priority
  2. Filed and published
  3. Projected expiry
  4. Today

106 members in 54 offices

This recordMember, by publication datePriority claim44 more offices are in the list below

Priority claims6

Priority claims
DocumentOfficeKindDate
14213099United States of AmericaP
0018263United States of AmericaW
60142130–––
PCTUS0018263–––
US19990142130P–––
WO2000US18263–––

Members106

Family members, oldest first
DocumentOfficeKind
CA2383630A1CanadaA1
DZ3191A1AlgeriaA1
WO0102369A2World Intellectual Property Organization (WIPO)A2
AU5785200AAustraliaA
UY26231A1UruguayA1
PE20010306A1PeruA1
NO20015797D0NorwayD0
IS6207AThis recordIcelandA
GT200000107AGuatemalaA
NO20015797LNorwayL
NO20060596LNorwayL
KR20020027379ARepublic of KoreaA
WO0102369A3World Intellectual Property Organization (WIPO)A3
BR0012352ABrazilA
EP1218348A2European Patent Office (EPO)A2
IL146710D0IsraelD0
PA8498001A1PanamaA1
CO5190686A1ColombiaA1
EA200200120A1Eurasian Patent Organization (EAPO)A1
MXPA01012795AMexicoA
CZ20014634A3CzechiaA3
BG106380ABulgariaA
CN1374950AChinaA
SK19252001A3SlovakiaA3
HU0202490A2HungaryA2
SV2002000121AEl SalvadorA
HU0202490A3HungaryA3
JP2003503481AJapanA
ZA200110061BSouth AfricaB
EE200100717AEstoniaA
US6531491B1United States of AmericaB1
US6534524B1United States of AmericaB1
HK1048813A1Hong Kong, ChinaA1
NZ516676ANew ZealandA
HRP20020109A2CroatiaA2
CN1137884CChinaC
EA004460B1Eurasian Patent Organization (EAPO)B1
CN1495171AChinaA
PL355757A1PolandA1
UA66933C2UkraineC2
AR035554A1ArgentinaA1
US2004171634A1United States of AmericaA1
YU92901AYugoslavia, later Serbia and Montenegro (until 2006)A
AU777701B2AustraliaB2
US2004220248A1United States of AmericaA1
MA26803A1MoroccoA1
HK1065037A1Hong Kong, ChinaA1
US2005038097A1United States of AmericaA1
US6884890B2United States of AmericaB2
US6891044B2United States of AmericaB2
US2005124662A1United States of AmericaA1
JO2319B1JordanB1
AP1486AAfrican Regional Intellectual Property Organization (ARIPO)A
TNSN00146A1TunisiaA1
CN1234693CChinaC
EP1614683A1European Patent Office (EPO)A1
KR100529639B1Republic of KoreaB1
OA11980AAfrican Intellectual Property Organization (OAPI)A
GEP20063885BGeorgiaB
HK1085470A1Hong Kong, ChinaA1
CR6517ACosta RicaA
TWI262914BTaiwan Province of ChinaB
NO322507B1NorwayB1
US7141581B2United States of AmericaB2
US7141587B2United States of AmericaB2
JP2006348043AJapanA
JP3878849B2JapanB2
JP3969669B2JapanB2
EP1218348B1European Patent Office (EPO)B1
AT376543TAustriaT
EP1614683B1European Patent Office (EPO)B1
DE60036879D1GermanyD1
PT1218348EPortugalE
DE60037211D1GermanyD1
PT1614683EPortugalE
DE60036879T2GermanyT2
DK1218348T3DenmarkT3
SI1218348T1SloveniaT1
SI1614683T1SloveniaT1
DK1614683T3DenmarkT3
ES2293906T3SpainT3
ES2296014T3SpainT3
HRP20020109B1CroatiaB1
CR10194ACosta RicaA
CA2383630CCanadaC
DE60037211T2GermanyT2
MY137622AMalaysiaA
SK286936B6SlovakiaB6
AR065937A2ArgentinaA2
RS50339BSerbiaB
MY139999AMalaysiaA
CZ301667B6CzechiaB6
BG66070B1BulgariaB1
ME00385BMontenegroB
MEP45108AMontenegroA
IS2791BIcelandB
PL212108B1PolandB1
EE05585B1EstoniaB1
CY1107147T1CyprusT1
NO2013004I1NorwayI1
Showing 100 of 106